Cargando…

The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene

PURPOSE: To investigate the effect of total glucoside of paeony (TGP) on gut microbiota in NOD mice with Sjögren’s syndrome (SS), using high-throughput sequencing of 16SrRNA gene. METHODS: Twenty-four NOD mice were randomly assigned to 4 groups (n = 6 per group): sham group receiving deionized water...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wen-Wen, Fu, Tian-Xiao, Wang, Qing, Chen, Yi-Lian, Li, Tian-Yi, Wu, Guo-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291443/
https://www.ncbi.nlm.nih.gov/pubmed/32536964
http://dx.doi.org/10.1186/s13020-020-00342-w
_version_ 1783545907382321152
author Lu, Wen-Wen
Fu, Tian-Xiao
Wang, Qing
Chen, Yi-Lian
Li, Tian-Yi
Wu, Guo-Lin
author_facet Lu, Wen-Wen
Fu, Tian-Xiao
Wang, Qing
Chen, Yi-Lian
Li, Tian-Yi
Wu, Guo-Lin
author_sort Lu, Wen-Wen
collection PubMed
description PURPOSE: To investigate the effect of total glucoside of paeony (TGP) on gut microbiota in NOD mice with Sjögren’s syndrome (SS), using high-throughput sequencing of 16SrRNA gene. METHODS: Twenty-four NOD mice were randomly assigned to 4 groups (n = 6 per group): sham group receiving deionized water (0.4 ml), hydroxychloroquin group receiving hydroxychloroquin (0.4 ml), TGP group receiving TGP (0.4 ml), and TGP + hydroxychloroquin group receiving 0.4 ml TGP and 0.4 ml hydroxychloroquin. Balb/c mice (n = 6) receiving 0.4 ml deionized water were used as a control group. After intragastric injection of drugs for 8 weeks, feces were collected for high-throughput sequencing of 16SrRNA gene. RESULTS: The sequencing of 16SrRNA gene resulted in 3686 OTUs, and 10 phyla and 69 genera were identified. Compared with the control group, the indices of Chao, Ace and Shannon in the other 4 groups were significantly lower (P < 0.05), and the Simpson index were significantly higher in the TGP, hydroxychloroquine, and sham groups (P < 0.05). Compared with the sham group, the indices of Chao, Ace and Shannon were significantly higher (P < 0.05), whereas the Simpson index was significantly lower (P < 0.05) in the TGP and TGP + hydroxychloroquine groups. At phylum level, Bacteroidetes was least abundant (36.1%), and Firmicutes was most abundant (56.28%) in the TGP + hydroxychloroquine group. Compared with the other 4 groups, Bacteroidetes was significantly less abundant (P < 0.05) and Firmicutes was significantly more abundant (P < 0.05) in the TGP + hydroxychloroquine group. Verrucomicrobia was most abundant (12.26%) in the hydroxychloroquine, and was significantly more abundant compared with the other 3 groups (P < 0.05). At genus level, compared with the control group, the abundance of Lactobacillus and Incertae of Phylum Firmicutes and Desulfovibrio of Phylum Proteobacteria was significantly increased, and the abundance of Bacteroides and Alloprevotella of Phylum Bacteroidetes and Pseudoflavonifractor of Phylum Firmicutes was significantly decreased in the TGP + hydroxychloroquine group (P < 0.05). Compared with the hydroxychloroquine group, the abundance of Akkermansia of Phylum Verrucomicrobia was significantly decreased in the TGP and TGP + hydroxychloroquine groups (P < 0.05). The abundance of Alistipes of Phylum Bacteroidetes and Desulfovibrio of Phylum Proteobacteria was significantly increased in the TGP + hydroxychloroquine group (P < 0.05). CONCLUSIONS: TGP increases the growth of many key beneficial bacteria, inhibits the growth of dominant pathogenic bacteria, and increases the diversity and abundance of gut microorganisms, especially when combined with hydroxychloroquine. Our findings suggest that TGP may be effective to treat SS by improving the microecological structure of the gut.
format Online
Article
Text
id pubmed-7291443
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72914432020-06-12 The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene Lu, Wen-Wen Fu, Tian-Xiao Wang, Qing Chen, Yi-Lian Li, Tian-Yi Wu, Guo-Lin Chin Med Research PURPOSE: To investigate the effect of total glucoside of paeony (TGP) on gut microbiota in NOD mice with Sjögren’s syndrome (SS), using high-throughput sequencing of 16SrRNA gene. METHODS: Twenty-four NOD mice were randomly assigned to 4 groups (n = 6 per group): sham group receiving deionized water (0.4 ml), hydroxychloroquin group receiving hydroxychloroquin (0.4 ml), TGP group receiving TGP (0.4 ml), and TGP + hydroxychloroquin group receiving 0.4 ml TGP and 0.4 ml hydroxychloroquin. Balb/c mice (n = 6) receiving 0.4 ml deionized water were used as a control group. After intragastric injection of drugs for 8 weeks, feces were collected for high-throughput sequencing of 16SrRNA gene. RESULTS: The sequencing of 16SrRNA gene resulted in 3686 OTUs, and 10 phyla and 69 genera were identified. Compared with the control group, the indices of Chao, Ace and Shannon in the other 4 groups were significantly lower (P < 0.05), and the Simpson index were significantly higher in the TGP, hydroxychloroquine, and sham groups (P < 0.05). Compared with the sham group, the indices of Chao, Ace and Shannon were significantly higher (P < 0.05), whereas the Simpson index was significantly lower (P < 0.05) in the TGP and TGP + hydroxychloroquine groups. At phylum level, Bacteroidetes was least abundant (36.1%), and Firmicutes was most abundant (56.28%) in the TGP + hydroxychloroquine group. Compared with the other 4 groups, Bacteroidetes was significantly less abundant (P < 0.05) and Firmicutes was significantly more abundant (P < 0.05) in the TGP + hydroxychloroquine group. Verrucomicrobia was most abundant (12.26%) in the hydroxychloroquine, and was significantly more abundant compared with the other 3 groups (P < 0.05). At genus level, compared with the control group, the abundance of Lactobacillus and Incertae of Phylum Firmicutes and Desulfovibrio of Phylum Proteobacteria was significantly increased, and the abundance of Bacteroides and Alloprevotella of Phylum Bacteroidetes and Pseudoflavonifractor of Phylum Firmicutes was significantly decreased in the TGP + hydroxychloroquine group (P < 0.05). Compared with the hydroxychloroquine group, the abundance of Akkermansia of Phylum Verrucomicrobia was significantly decreased in the TGP and TGP + hydroxychloroquine groups (P < 0.05). The abundance of Alistipes of Phylum Bacteroidetes and Desulfovibrio of Phylum Proteobacteria was significantly increased in the TGP + hydroxychloroquine group (P < 0.05). CONCLUSIONS: TGP increases the growth of many key beneficial bacteria, inhibits the growth of dominant pathogenic bacteria, and increases the diversity and abundance of gut microorganisms, especially when combined with hydroxychloroquine. Our findings suggest that TGP may be effective to treat SS by improving the microecological structure of the gut. BioMed Central 2020-06-11 /pmc/articles/PMC7291443/ /pubmed/32536964 http://dx.doi.org/10.1186/s13020-020-00342-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lu, Wen-Wen
Fu, Tian-Xiao
Wang, Qing
Chen, Yi-Lian
Li, Tian-Yi
Wu, Guo-Lin
The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title_full The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title_fullStr The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title_full_unstemmed The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title_short The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
title_sort effect of total glucoside of paeony on gut microbiota in nod mice with sjögren’s syndrome based on high-throughput sequencing of 16srrna gene
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291443/
https://www.ncbi.nlm.nih.gov/pubmed/32536964
http://dx.doi.org/10.1186/s13020-020-00342-w
work_keys_str_mv AT luwenwen theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT futianxiao theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT wangqing theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT chenyilian theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT litianyi theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT wuguolin theeffectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT luwenwen effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT futianxiao effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT wangqing effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT chenyilian effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT litianyi effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene
AT wuguolin effectoftotalglucosideofpaeonyongutmicrobiotainnodmicewithsjogrenssyndromebasedonhighthroughputsequencingof16srrnagene